Insight Lifetech
PublicInsight Lifetech is now publicly traded
The data on this page reflects Insight Lifetech's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Series D
Extension
Sep 28, 2022
Total Funding Raised
$172.1M
Company Overview
Insight Lifetech is a medical technology company that develops and manufactures advanced heart intervention equipment designed to enhance the diagnosis and treatment of cardiovascular diseases.
Sector
Healthcare/Wellness
AI Layer
Application
Keywords
Insight Lifetech Comparables
Compare Insight Lifetech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tianjin Hengyu Medical Technology Co., Ltd. | 81% | |
| Provisio Medical | 69% |
Insight Lifetech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Sep 28, 2022 | ||||
| Series D | Jun 30, 2021 | ||||
| Series C | Dec 31, 2020 | ||||
| Series B Extension | Apr 7, 2020 | ||||
| Series B | Nov 1, 2018 |
Key People
Founding team and executive leadership
Insight Lifetech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boyu Capital | Series D |
| Triwise Capital | Series D Extension |
| China Taiping Insurance Group | Series D Extension |
| Far East Horizon | Series D Extension |
| Lotus Lake Capital Management | Series B Extension |
| Efung Capital | Series B Extension |
| Sherpa Healthcare Partners | Series D Extension |
Insight Lifetech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access